Literature DB >> 32070705

Reconstitution of Highly Concentrated Lyophilized Proteins: Part 1 Amorphous Formulations.

Pooja Sane1, Robin H Bogner2, Bakul Bhatnagar3, Serguei Tchessalov3.   

Abstract

Long reconstitution times before patient administration remain an undesirable quality attribute for high concentration lyophilized protein formulations. In this study, 3 approaches were developed to study reconstitution behavior of lyophilized, amorphous cakes of a highly concentrated monoclonal antibody (mAb) by exploring their wetting, disintegration, and hydration behavior. As the mAb concentration increased from 0 to 83 mg/mL, reconstitution times were longer with poorer wetting, slower hydration, and disintegration rates. Furthermore, the effect of controlling ice nucleation temperature at -5 and -10°C during freezing followed by either conservative or aggressive drying conditions on the reconstitution times was explored in formulations containing 40 and 83 mg/mL mAb. Although no effect of either of the 2 processing conditions was noted at 40 mg/mL, aggressive drying led to faster reconstitution at both the nucleation temperatures with 83 mg/mL mAb. The present study combined with literature data suggests that below a protein-to-sugar ratio of 1, reconstitution was complete within 1 min, and when the ratio was greater than 1, the reconstitution times increased nonlinearly. Disintegration and hydration were determined to be the key mechanisms contributing to the complete reconstitution of the lyophilized, amorphous cakes of the highly concentrated mAb in vials.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  contact angle; dissolution; high concentration; hydration; lyophilization; protein(s); wetting

Mesh:

Substances:

Year:  2020        PMID: 32070705     DOI: 10.1016/j.xphs.2020.02.006

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  Spin Freezing and Its Impact on Pore Size, Tortuosity and Solid State.

Authors:  Joris Lammens; Niloofar Moazami Goudarzi; Laurens Leys; Gust Nuytten; Pieter-Jan Van Bockstal; Chris Vervaet; Matthieu N Boone; Thomas De Beer
Journal:  Pharmaceutics       Date:  2021-12-09       Impact factor: 6.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.